1. Murata H, Kita Y, Sakamoto A, Matsumoto I, Matsumura R, Sugiyama T, Sueishi M, Takabayashi K, Iwamoto I, Saitoh Y, Nishioka K, Iwamoto I, Sumida T. Limited TCR repertoire of infiltrating T cells in the kidneys of Sjogren's syndrome patients with interstitial nephritis. J. Immunol. 1995 ; 155 : 4084-4089

2. Matsumoto I, Tsubota K, Satake Y, Kita Y, Matsumura R, Murata H, Namekawa T, Nishioka K, Iwamoto I, Saitoh Y, Sumida T. Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjogren's syndrome. J. Clin. Invest. 1996 ; 97 : 1969-1977

3. Sumida T, Matsumoto I, Murata H, Namekawa T, Matsumura R, Tomioka H, Iwamoto I, Saito Y, Mizushima Y, Hasunuma T, Maeda T, Nishioka K. TCR in Fas-sensitive T cells from labial salivary glands of patients with Sjogren's syndrome. J. Immunol. 1997 ; 158 : 1020-1025

4. Sumida T, Matsumoto I, Maeda T, Nishioka K. T-cell receptor in Sjogren's syndrome. Br. J. Rhematol. 1997 ; 36 : 622-629

5. Sumida T, Kato T, Hasunuma T, Maeda T, Nishioka K, Matsumoto I.. Regulatory T cell epitope recognized by T cells from labial salivary glands of patients with Sjogren's syndrome. Arthritis.Rheum. 1997 ; 40 : :2271-2273

6. Matsumoto I, Maeda T, Takemoto Y, Hashimoto Y, Kimura F, Iwamoto I, Saito Y, Nishioka K, Sumida T. α-amylase functions as a salivary gland-specific self T cell epitope in patients with Sjogren's syndrome. Int. J. Mol. Med. 1999 ; 3 : 485-490

7. Keino H, Matsumoto I, Okada S, Kurokawa M, Kato T, Tokuhisa T, Usui M, Taniguchi M, Nishioka K, Sumida T. A single cell analysis of TCR AV24AJ18+DN T cells. Microbiol. Immunol. 1999 ; 43 : 577-584

8. Matsumoto I, Okada S, Kuroda K, Iwamoto I, Saito Y, Tokuhisa T, Nishioka K, Sumida T. Single cell analysis of T cells infiltrating labial salivary glands from patients with Sjogren's syndrome. Int. J. Mol.Med. 1999 ; 4 : 519-527

9. Matsumoto I, Staub A, Benoist C, Mathis D. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science. 1999 ; 286 : 1732-1735

10. Wang M, Keino H, Matsumoto I, Kurokawa M, Kato T, Nishioka K, Sumida T. 　　A single cell analysis of Fas ligand positive T cells in rheumatoid synovial fluid. J. Rheumatol. 2000 ; 27 : 311-318

11. Basu D, Horvath S, Matsumoto I, Fremont DH、 Allen PM.. Molecular basis for recognition of an arthritic peptide and a foreign epitope on distinct MHC molecules by a single TCR. 　J.Immunol. 2000 ; 164 : 5788-5796

12.Matsumoto I, Maccioni M, Lee DM, Maurice M, Simmons B, Brenner M, Mathis D, Benoist C . How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nature Immunol.(2002;3:360-365)

13.Matsumoto I, Sumida T: B Cells and Immunoglobulins Dependent Mechanisms in Rheumatoid Arthritis: A Possible Rationale of the Extracorporeal Immunomodulation for Rheumatoid Arthritis. Therapeutic Apheresis. 6:317-319,2002

14.Matsumoto I, Lee DM, Mansky RG, Sumida T, Hitchon CA, Schur PH, Anderson RJ, Coblyn SJ, Weinblatt ME., Brenner M, Duclos B, Pasquali JL, Gabalawy HE, Mathis D, and Benoist C:Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders. Arthritis and Rheumatism 48:944-954,2003

15.Tsutsumi A., Ikegami H., Takahashi R., Murata H., Goto D., Matsumoto I., Fujisawa T., and Sumida T.: Mannose binding lectin gene polymorphism in patients with type I diabetes. Human Immunology. 64: 621-624, 2003

16. Murata H., Adachi Y., Ebitsuka T., Chino Y., Takahashi R., Hayashi T., Goto D., Matsumoto I., Tsutsumi A., Akaza H., and Sumida T.:
Reiter's syndrome following intravesical Bacille bilie de Calmette-Guerin treatment for superficial bladder carcinoma. Report of six cases Mod. Rheumatol. 14:82-86,2004

17.Muraki Y., Tsutsumi A., Takahashi R., Suzuki E., Hayashi T., Chino Y., Goto D., Matsumoto I., Murata H., and Sumida T. Polymorphisms of IL-1b gene in japanese patients with Sjogren's syndrome and systemic lupus erythematosus. J. Rheumatol. 31:720-725,2004

18. Takahashi R., Tsutsumi A., Ohtani K., Goto D., Matsumoto I., Ito S., Wakamiya N., and Sumida T.:
Anti-mannose binding lection antibodies in sera of Japanese patients with systemic lupus erythematosus. Clin.Exp.Immunol. 136(3):585-590,2004

19.Muraki Y., Matsumoto I., Chino Y., Hayashi T., Suzuki E., Goto D., Ito S., Murata H., Tsutsumi A., Sumida T.:
Glucose-6-phosphate isomerase variants play a key role in the generation of anti-GPI antibodies.Possible mechanism of autoantibody production
Biochem. Biophys. Research. Commun.323(2):518-522,2004

20.Takahashi R., Tsutsumi A., Ohtani K., Muraki Y., Goto D., Matsumoto I., Wakamiya N., and Sumida T.:
Association of mannose-binding lection(MBL) gene polymorphism and serum MBL concentration with characteristics and progression of systemic lupus erythematosus.
Ann. Rheum. Dis.64(2):311-314,2005

21.Naito Y., Matsumoto I., Wakamatsu E., Goto D., Sugiyama T., Matsumura R., Ito S., Tsutsumi A., Sumida T.:
Muscariinic acetylcholine recepter auto antibodies in patients with Sjogren's syndrome.
Ann. Rheum. Dis.64(3):510-511,2005

22. Tomoo T., Tsutsumi A., Yasukochi T., Ikeda T., Ochiai N., Ozawa K., Shibanaka Y., Ito S., Matsumoto I., Goto D., Sumida T.:
Analysis of abnormally expressed genes in synovium from patients with rheumatoid arthritis using a column gel electrophoresis-coupled subtractive hybridization technique.
Int. J. Mol. Med.15(3):453-457,2005

23.Suzuki T., Muraki Y., Yasukochi T., Hua Zhang., Kori Y., Wakamatsu E., Hayashi T., Goto D., Ito S., Tsutsumi A., Sumichika H., Sumida T., Matsumoto I.:
Immunoglobulin G from anti-glucose-6-phosphate isomerase antibodies positive patient with rheumatoid arthritis induces synovitis in cynomolgus monkeys
Autoimmunity Reviews 4:475-478,2005

24.Hayashi T, Matsumoto I, Muraki Y, Takahashi R, Chino Y, Goto D, Ito S, Tsutsumi A, Sumida T.:
Clinical Characteristics of Anti-Glucose-6-Phosphate Isomerase Antibodies positive Japanese Patients with Rheumatoid Arthritis
Modern Rheumatoloogy 15:258-263,2005

25.Matsumoto I, Muraki Y, Yasukochi T, Hua Zhang, Kori Y, Hayashi T, Goto D, Ito S, Tsutsumi A, Ikeda K, Sumichika H, Sumida T.:
The exploration of joint-specific immunoreactions on immunoglobulins G of anti-glucose-6-phosphate isomerase antibody-positive patients with rheumatoid arthritis
Int. J. Mol. Med .16(5):793-800,2005

26.Matsumoto I, Hua Zhang, Muraki Y, Hayashi T, Yasukochi T, Kori Y, Goto D, Ito S, Tsutsumi A, Sumida T.:
A functional variant of Fcy receptor IIIA is associated with rheumatoid arthritis in anti-glucose-6-phosphate isomerase antibodies-positive individuals
Arthritis. Res. Ther. 7:1183-1188,2005

27.Miyahara S, Ito S, Soeda A, Chino Y, Hayashi T, Takahashi R, Goto D, Matsumoto I, Tsutsumi A, Sumida T.:
Two cases of systemic lupus erythematosus complicated with colonic ulcers.
Intern Med.44(12)1298-1306,2005

28.Kori Y., Matsumoto I., Hua Zhang., Yasukochi T., Hayashi T., Iwanami K., Goto D., Ito S., Tsutsumi A., Sumida T.:
Characterization of Th1/Th2 type, glucose-6-phosphate isomerase reactive T cells in the generation of rheumatoid arthritis
Ann. Rheum. Dis.65:968-969,2006

29.Ito S, Sugihara M, Suzuki T, Mamura M, Goto D, Matsumoto I, Tsutsumi A, Sumida T.:
Diagnosis of Chlamydia-induced reactive arthritis
Intern Med(letter)45(1)37-37,2006

30.Ohnishi Y, Tsutsumi A, Goto D, Ito S, Matsumoto I, Taniguchi M,Sumida T.:
TCRVa14+NKT cells function as effector T cells in collagen-induced arthritis mice
Clin. Exp. Immunol. 141:47-53,2005

31.Kitagawa M, Goto D, Mamura M, Matsumoto I, Ito S, Tsutsumi A, Sumida T.:
Inhibitory peptides of CD40/CD154 interaction.
Mod.Rheumatol. 15:423-426,2005

32.Naito Y, Matsumoto I, Wakamatsu E, Goto D, Ito S, Tsutsumi A, Sumida T.:
Altered peptide ligants regulate muscarinic acetylcholine receptor reactive T cells of patients with Sjogren's Syndrome
Ann. Rheum. Dis. 65:269-271,2006

33.Chino Y, Murata H, Goto D, Matsumoto I, Tsutsumi A, Sakamoto T, Ohtsuka M, Sekisawa K, Ito S, Sumida T.:
T cell receptor BV gene repertoire in lymphocytes from bronchoalveolar lavage fjuid of polymyositis/dermatomyositis patients with interstitial pneumonitis.
Int. J. Mol. Med. 17:101-109,2006

34.Suzuki E, Tsutsumi A, Goto D, Matsumoto I, Ito S, Otsu M, Onodera M, Takahashi S, Sato Y, Sumida T.:
Gene transduction of tristetraprolin or its active domain reduces TNF-α production in Jurkat T cells.
Int.I.Mol.Med. 17(5)801-809,2006

35.Suzuki E, Hayashi T Ito S, Miyazaki K, Yamazaki H, Machino T, , Takahashi R, Chino Y, Goto D, Matsumoto I, Tsutsumi A, Sato Y, Sumida T.:
A Case of Pulmonary Hypertension Associated with Systemic Lupus Erythematosus without Anti-ribonucleoprotein Antibodies.
ACTA MEDICA et BIOLOGICIA 53(3)87-93,2005

36.Kai H, Shibuya K, Wang Y, Kameta H, Kameyama T, Tahara-Hanaoka S, Miyamoto A, Honda S, Matsumoto I, Koyama A, Sumida T, Shibuya A.:
Critical role of M.tuberculosis for dendritic cell maturation to induce collagen-induced arthritis in H-2b background of C57BL/6 mice
Immunology 118 233-239,2006

37.Tsutsumi A, Hayashi T, Chino Y, Goto D, Matsumoto I, Ito S, Sumida T.:
Significnace of antiprothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other phospholipids antibody assays.
Mod.Rheumatol.16:158-164,2006

38.Sumida T, Wakamatsu E, Nakamura Y, Matsumoto I.:
Autoantibodies against muscarinic acetylcholine receptor in patients with Sjogren's syndrome.(review)
In Textbook of autoantibodies Second Edition ed. by Y. Shoenfeld, M. E. Gershwin and P. L. Meroni. Elsevier, 681-686, 2007

39.Wakamatsu E, Matsumoto I, Yasukochi T, Naito Y, Goto D, Mamura M, Ito S, Tsutsumi A, Sumida T.:
Overexpression of phosphorylated stat1-α in labial salivary glands of patients with Sjogren's Syndrome
Arthritis Rheum 54(11)3476-3484,2006

40.Ohnishi Y, Tsutsumi A, Matsumoto I, Goto D, Ito S, Kuwana M, Uemura Y, Nishimura Y, Sumida T.:
Altered peptide ligands control type ?collagen-reactive T cells from RA patients
Mod.Rheumatol.16:226-228,2006

41.Suzuki E, Tsutsumi A, Sugihara M, Mamura M, Goto D, Matsumoto I, Ito S, Ikeda K, Ochiai N, Sato Y, Sumida T.:
Expression of TNF-α, tristetraprolin, T-cell intracellular antigen-1 and Hu antigen R genes in synobium of patients with rheumatoid arthritis.
Int.J.Mol.Med. 18:273-278,2006

42.Wakamatsu E, Nakamura Y, Matsumoto I, Goto D, Ito S, Tsutsumi A, Sumida T.:
DNA microarray analysis of labial salivary gland of patients with Sjogren's syndrome
Ann. Rheum. Dis. 66:844-845,2007

43.Yamada H, Ishii W, Ito S, Iwanami K, Ogishima H, Suzuki T, Mamura M, Goto D, Matsumoto I, Tsutsumi A, Sumida T.:
Sarcoid myositis with muscle weakness as a presenting symptom
Mod Rheumatol 17：243-246，2007

44.Matsuyama M, Suzuki T, Tsuboi H, Ito S, Mamura M, Goto D, Matsumoto I, Tsutsumi A, Sumida T.:
Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease.
Inten Med 46, 771-774, 2007

45.Sugihara M, Tsutsumi A, Suzuki E, Wakamatsu E, Suzuki T, Ogishima H, Hayashi T, Chino Y, Ishii W, Mamura M, Goto D, Matsumoto I, Ito S, Sumida T.:
Effects of infliximab therapy on gene expression levels of tumor necrosis factor alpha, tristetraprolin, T cell intracellular antigen 1, and Hu antigen R in patients with rheumatoid arthritis.
Arthritis Rheum 56(7):2160-2169,2007

46.Enami T, Suzuki T, Ito S, Yoshimi A, Sugihara M, Mamura M, Hayashi T, Goto D, Matsumoto I, Tsutsumi A, and Sumida T.:
Successful treatment of refractory thrombotic thrombocytopenic purpura with cyclosporine and corticosteroids in a patient with systemic lupus erythematosus and antibodies to ADAMTS13
Intern Med 46:1033-1037,2007

47.Hayashi T, Matsumoto I, Yasukochi T, Mamura M, Goto D, Ito S, Tsutsumi A, Sumida T.:
Biased usage of synovial immunoglobulin heavy chain variable region 4 by the anti-glucose-6-phosphate isomerase antibody in patients with rheumatoid arthritis.
Int. J. Mol. Med.20(2):247-253,2007

48.Nakamura Y, Wakamatsu E, Matsumoto I, Tomiita M, Kohno Y, Mori M, Yokota S, Goto D, Ito S, Tsutsumi A, Sumida T.:
High prevalence of autoantibodies to muscarinic-3 acetylcholine receptor in patients with juvenile-onset Sjogren's syndrome
Ann. Rheum. Dis. 67(1)136-137,2008

49.Matsui H, Tsutsumi A, Sugihara M, Suzuki T, Iwanami K, Kohno M, Goto D, Matsumoto I, Ito S, Sumida T.:
Visfatin(pre-B cell colony-enhancing factor) gene expression in patients with rheumatoid arthritis
Ann. Rheum. Dis. 67(4):571-572,2008

50.Iwanami K, Matsumoto I, Watanabe Y, Mihara M, Ohsugi Y, Mamura M, Goto D, Ito S, Tsutsumi A, Kishimoto T, Sumida T.:
Crucial role of IL-6/IL-17 cytokine axis in the induction of arthritis by glucose-6-phosphate-isomerase.
Arthritis Rheum. 58(3):754-763 ,2008

51.Kohno M, Tsutsumi A, Matsui H,Sugihara M, Suzuki T, Mamura M, Goto D, Matsumoto I, Ito S, Suguro T, Sumida T.:
Interleukin 17 gene expression in patients with rheumatoid arthritis
Mod.Rheumatol 18:15-22,2008

52.Ishii W, Ito S, Kondo Y, Tsuboi H, Mamura M, Goto D, Matsumoto I, Tsutsumi A, Okoshi Y, Hasegawa Y, Kojima H, Sakashita S, Aita K, Noguchi M, Sumida T.:
Intravascular large B-cell lymphoma with acute abdomen as a presenting symptom in a patient with systemic lupus erythematosus
J. Clin. Oncol. 26(9):1553-1555,2008

53.Wang Y, Ito S, Chino Y, Iwanami K, Yasukochi T, Goto D, Matsumoto I, Hayashi T, Uchida K, Sumida T.:
Use of Laser Microdissection in the Analysis of Renal-infiltrating T cells in MRL/lpr Mice
Mod Rheumatol 18:385-393,2008

54.Furuya T, Matsumoto I, Tsuchiya N, Hakoda M, Ichikawa N, Higami K, Nanke Y, Sumida T, Kamatani N, Kotake S.:
Anti-glucose-6-phosphate isomerase, anti-cyclic citrullinated peptide antibodies and HLA-DRB1 genotypes in Japanese patients with early rheumatoid arthritis
Clin Exp Rheumatol 26(5):918-921,2008

55.Matusmoto I, Zhang H, Yasukochi T, Iwanami K, Tanaka Y, Inoue A, Goto D, Ito S, Tsutsumi A, Sumida T.:
Therapeutic effects of antibodies to TNF alpha and IL-6 and CTLA-4 Ig in mice with glucose-6-phosphate isomerase-induced arthritis
Arthritis Res Ther 10:R66,2008

56.Yoshiga Y, Goto D, Segawa S, Ohnishi Y, Matsumoto I, Ito S, Tsutsumi A, Taniguchi M,Sumida T.:
Invariant NKT cells produce IL-17 through IL-23-dependent and -independentpathways with potential modulation of Th17 response in collagen-induced arthritis.
Int.J.Mol.Med. 22:369-374,2008

57.Suzuki T, Tsutsumi A, Suzuki E, Sugihara M, Muraki Y, Hayashi T, Chino Y, Goto D, Matsumoto I, Ito S, Sumida T.:
Tristetraprolin(TTP) gene polymorphisms in patients with rheumatoid arthritis and healthy individuals
Mod. Rheumatol 18:472-479,2008

58.Kawaguchi Y, Nakamura Y, Matsumoto I, Nishimagi E, Kamatani N, Satoh T, Kuwana M, Sumida T, Hara M.:
Muscarinic-3 acetylcholine receptor autoantibody in patients with systemic sclerosis: contribution to severe gastrointestinal tract dysmotility
Ann. Rheum. Dis. 68:710-714,2009

59. Ito I, Kawasaki A, Ito S, Hayashi T, Goto D, Matsumoto I, Tsutsumi A, Geoffrey Hom, Robert R. Graham, Takasaki Y, Hashimoto H, Ohashi J, Timothy W. Behrens, Sumida T, Tsuchiya N.:
Replication of the Association between C8orf13-BLK Region and Systemic Lupus Erythematosus in a Japanese Population.
Arthritis Rheum. 60(2):553-558,2009

60.Kawasaki A, Ito I, Hikami K, Ohashi J, Hayashi T, Goto D, Matsumoto I, Ito S, Tsutsumi A, Koga M, Arinami T, Robert R Graham, Geoffrey Hom, Takasaki Y, Hashimoto H, Timothy W Behrens, Sumida T, Tsuchiya N.:
Role of STAT4 polymorphisms in systemic lupus erythematosus in a Japanese population: a case-control association study of STAT1-STAT4 region.
Arthritis Res Ther 10:R113,2008

61. Tanaka-Watanabe Y, Matsumoto I, Iwanami K, Inoue A, Goto D, Ito S, Tsutsumi A, Sumida T.:
B cell play crucial role as antigen presenting cells and collaborationg with inflammatory cytokines in glucose-6-phoaphate isomerase-induced arthritis.
Clin. Exp. Immunol. 155:285-294,2009

62.Iwanami K, Matsumoto I, Tanaka Y, Inoue A, Goto D, Ito S, Tsutsumi A, Sumida T.:
Arthritogenic T cell epitope in glucose-6-phosphate isomerase (GPI)-induced arthritis.
Arthritis Res Ther 10(6):R130. Epub ,2008

63.Tsutsumi A, Kobayashi T, Ito S, Goto D, Matsumoto I, Yoshie H, Sumida T.:
Mannose binding lection gene polymorphisms and the severity of chronic periodontitis.
Jap.J.Clin.Immunol 32:48-52,2009

64.Horikoshi M, Ito S, Ishikawa M, Umeda N, Kondo Y, Tsuboi H, Hayashi T, Goto D, Matsumoto I, Sumida T.:
Efficacy of mizoribine pulse therapy in patients with rheumatoid arthritis who show reduced or insufficient response to infliximab.
Mod Rheumatol 19:229-234,2009

65.Suzuki T, Ito S, Handa S, Kose K, Okamoto Y, Minami M, Hayashi T, Goto D, Matsumoto I, Sumida T.:
A new low-field extremity magnetic resonance imaging and proposed compact MRI score- Evaluation of anti-tumor necrosis factor biologics on rheumatoid arthritis.
Mod Rheumatol 19:358-365,2009

66.Wakamatsu E, Matsumoto I, Yoshiga Y, Hayashi T, Goto D, Ito S, Sumida T.:
Altered peptide ligands regulate type II collagen-induced arthritis in mice
Mod Rheumatol 19:366-371,2009

67.Kondo Y, Ito S,Ohi Y, Satou H, Hiraoka T, Tsuboi H, Sugihara M, Hayashi T, Goto D, Matsumoto I, Sumida T.:
Atypical Cogan's Syndrome with Aortitis.
Intern. Med 48:1093-1097,2009

68.Segawa S, Goto D, Yoshiga Y, Hayashi T, Matsumoto I, Ito S, Sumida T.:
Low levels of soluble CD1d protein alters NKT cell function in patients with rheumatoid arthritis.
Int. J. Mol. Med.24(4):481-486,2009

69.Inoue A, Matsumoto I, Tanaka Y, Iwanami K, Kanamori A, Ochiai N, Goto D, Ito S, Sumida T.:
Tumor necrosis factor alpha-induced adipose-related protein expression in experimental arthritis and in rheumatoid arthritis.
Arthritis Res Ther.11(4):R118. Epub 2009 Aug 6

70.Wang Y, Ito S, Chino Y, Goto D, Matsumoto I, Murata H, Tsutsumi A, Hayashi T, Uchida K, Usui J, Yamagata K,Sumida T.:
Laser Microdissection-based Analysis of Cytokine Balance in the Kidneys of Patients with Lupus Nephritis
Clin. Exp. Immunol. 159(1):1-10,2010

71.Ito I, Kawasaki A, Ito S, Kondo Y, Sugihara M, Horikoshi M, Hayashi T, Goto D, Matsumoto I, Tsutsumi A, Takasaki Y, Hashimoto H, Matsuta K, Sumida T, Tsuchiya N.:
Replication of association between FAM167A(C8orf13)-BLK region and rheumatoid arthritis in a Japanese population.
Ann. Rheum. Dis.69:936-937,2010

72.Iwanami K, Matsumoto I, Yoshiga Y, Inoue A, Kondo Y, Yamamoto K, Tanaka Y, Minami R, Hayashi T, Goto D, Ito S, Nishimura Y, Sumida T.:
Altered peptide ligands inhibit arthritis induced by glucose-6-phosphate isomerase peptide.
Arthritis Res Ther.11:R167,Epub2009 Nov 9

73.Umeda N, Ito S, Hayashi T, Goto D, Matsumoto I, Sumida T.:
A patient with rheumatoid arthritis who had a normal delivery under etanercept treatment.
Intern. Med.49:187-189,2010

74.Segawa S, Goto D, Yoshiga Y, Sugihara M, Hayashi T, Chino Y, Matsumoto I, Ito S, Sumida T.:
Inhibition of transforming growth factor-b signaling attenuates IL-18 plus IL-2-induced interstitial lung disease in mice.
Clin. Exp. Immunol.160:394-402,2010

75.Suzuki T, Ito S, Handa S, Kose K, Okamoto Y, Minami M, Sugihara M, Horikoshi M, Tsuboi H, Hayashi T, Goto D, Matsumoto I, Sumida T.:
New low-field extremity MRI, compacTscan: comparison with whole body 1.5 tesla conventional MRI.
Mod. Rheumatol.20(4):331-336,2010

76. Kawasaki A, Ito I, Ito S, Hayashi T, Goto D, Matsumoto I, Takasaki Y, Hashimoto H, Sumida T, Tsuchiya N.:
Association of TNFAIP3 polymorphism with susceptibility to systemic lupus erythematosus in a Japanese population.
Journal of Biomedicine and Biotechnology.Epub 2010 May 27

77.Sumida T, Tsuboi H, Iizuka M, Nakamura Y, Matsumoto I.:
Functional role of M3 muscarinic acetylcholine receptor (M3R) reactive T cells and anti-M3R autoantibodies in patients with Sjogren's syndrome.
Autoimmunity Reviews 9:615-617,2010

78.Ogishima H, Ito S, Tsutsumi A, Sugihara M, Goto D, Matsumoto I, Obata-Yasuoka M,  Hamada H, Yoshikawa H, Takahashi H, Murashima A, Sumida T.:
High dose unfractionated heparin therapy in a pregnant patient with antiphospolipid syndrome: a case report
International Journal of Rheumatic Diseases 13(3):e32-e35,2010

79.Tsuboi H, Matsumoto I, Wakamatsu E, Nakamura Y, Iizuka M, Hayashi T, Goto D, Ito S, Sumida T.:
New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjogren’s syndrome.
Clin. Exp. Immunol.162:53-61, 2010

80.Hayashi T, Ito S, Goto D, Matsumoto I, Sumida T.:
Elevated level of serum cystatin-C concentration is a useful predictor for myelosuppression induced by methotrexate for treatment of rheumatoid arthritis.
Modern Rheumatology 20:548-555,2010

81. Chen Q, Muramoto K, Masaaki N, Ding Y, Yang H, Mackey M, Li W, Inoue Y, Ackermann K, Shirota H, Matsumoto I, Spyvee M, Schiller S, Sumida T, Gusovsky F, Lamphier M.
A novel antagonist of the prostaglandin E(2) EP(4) receptor inhibits Th1 differentiation and Th17 expansion and is orally active in arthritis models.
Br J Pharmacol. 2010 May;160(2):292-310.

82.Horikoshi M, Suzuki T, Sugihara M, Kondo Y, Tsuboi H, Uehara T, Hama M, Takase K, Ohno S, Ishigatsubo Y, Yoshida Y, Sagawa A, Ikeda K, Ota T, Matsumoto I, Ito S, Sumida T.:
Comparison of low-field dedicated extremity magnetic resonance imaging with articular ultrasonography in patients with rheumatoid arthritis.
Modern Rheumatology 20:556-560,2010

83.Iizuka M, Wakamatsu E, Tsuboi H, Nakamura Y, Hayashi T, Matsui M, Goto D, Ito S, Matsumoto I, Sumida T.:
Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjogren's syndrome-like sialoadenitis.
J.Autoimmunity 35:383-389,2010

84.Tsuboi H, Wakamatsu E, Iizuka M, Nakamura Y, Sugihara M, Suzuki T, Ogishima H, Hayashi T, Goto D, Ito S, Matsumoto I, Sumida T.:
Importance of serine727 phosphorylated STAT1 in IFNgamma-induced signaling and apoptpsis of human salivary gland cells.
Int J Rheum Dis 14:86-91,2011

85.Kawasaki A, Ito S, Furukawa H, Hayashi T, Goto D, Matsumoto I, Kusaoi M, Ohashi J, Graham R R, Matsuta K, Behrens T W, Tohma S, Takasaki Y, Hashimoto H, Sumida T, Tsuchiya N.:
Association of TNFAIP3 interacting protein 1, TNIP1 with systemic lupus erythematosus in a Japanese population : a case-control association study.
Arthritis Res. Ther.12:R174,2010

86.Hikami K, Kawasaki A, Ito I, Koga M, Ito S, Hayashi T, Matsumoto I, Tsutsumi A, Kusaoi M, Takasaki Y, Hashimoto H, Arinami T, Sumida T, Tsuchiya N.:
Association of a functional polymorphism in the 3' untranslated region of SPI1 with systemic lupus erythematosus.
Arthritis Rheum. 63:755-763,2011

87.Akashi N, Matsumoto I, Tanaka Y, Inoue A, Yamamoto K, Tanaka Y, Umeda N, Hayashi T, Goto D, Ito S, Sekiguchi K, Sumida T.:
Comparative suppressive effect in models of autoimmune arthritis by tyrosine kinase inhibitors imatinib and nilotinib.
Mod. Rheumatol 21:267-275,2011

88.Segawa S, Goto D, Yoshiga Y, Horikoshi M, Sugihara M, Hayashi T, Chino Y, Matsumoto I, Ito S, Sumida T.:
Involvement of NK 1.1-Positive {gamma}{delta}T Cells in Interleukin-18 Plus Interleukin-2-Induced Interstitial Lung Disease.
Am. J. Res. Cell. Mol. Biol. 45(3):659-666,2011

89.Yoshiga Y, Goto D, Segawa S, Horikoshi M, Hayashi T, Matsumoto I, Ito S, Taniguchi S, Sumida T.:
Activation of natural killer T cells by α-carba-GalCer (RCAI-56), a novel synthetic glycolipid ligand, suppresses murine collagen-induced arthritis.
Clin. Exp. Immunol. 164(2):236-247,2011

90.Kawasaki A, Furukawa H, Kondo Y, Ito S, Hayashi T, Kusaoi M, Matsumoto I, Tohma S, Takasaki Y, Hashimoto H, Sumida T, Tsuchiya N.:
Toll-like receptor 7(TLR7) SNPs in the 3' untranslated region and intron additively contribute to susceptibility to systemic lupus erythematosus in a Japanese female population.
Arthritis Res. Ther.13(2):R41,2011

91.Koga M, Kawasaki A, Ito I, Furuya T, Ohashi J, Kyogoku C, Ito S, Hayashi T, Matsumoto I, Kusaoi M, Takasaki Y, Hashimoto H, Sumida T, Tsuchiya N.:
Cumulative Association of Eight Susceptibility Genes with Systemic Lupus Erythematosus in a Japanese Female Population.
Journal of Human Genetics 56:503-507,2011

92.Tanaka Y, Matsumoto I, Iwanami K, Inoue A, Minami R, Umeda N, Kanamori A, Ochiai N, Miyazawa K, Sugihara M, Hayashi T, Goto D, Ito S, Sumida T.:
Six-transmembrane epithelial antigen of prostate4(STEAP4) is TNFalpha-induced protein that regulates IL-6, Il-8, and cell proliferation in synovium from patients with rheumatoid arthritis
Mod. Rheumatol 22:128-136, 2012

93.Kondo Y, Iizuka M, Wakamatsu E, Yao Z, Tahara M, Tsuboi H, Sugihara M, Hayashi T, Yoh K, Takahashi S, Matsumoto I, Sumida T.:
Overexpression of T-bet gene regulates murine autoimmune arthritis
Arthritis Rheum.64(1):162-172,2012

94.Tsuboi H, Nakamura Y, Iizuka M, Matsuo N, Matsumoto I, Sumida T.:
Generation and functional analysis of monoclonal antibodies against the second extracellular loop of human M3 muscarinic acetylcholine receptor
Mod. Rheumatol.22(2):264-271,2012

95.Tanaka Y, Matsumoto I, Iwanami K, Inoue A, Umeda N, Tanaka Y, Sugihara M, Hayashi T, Ito S, Sumida T.
Six-transmembrane epithelial antigen of prostate4 (STEAP4) is expressed on monocytes/neutrophils, and is regulated by TNF antagonist in patients with rheumatoid arthritis.
Clin. Exp. Rheumatol.30(1):99-102,2012

96.Kawasaki A, Furukawa H, Kondo Y, Ito S, Hayashi T, Kusaoi M, Matsumoto I, Tohma S, Takasaki Y, Hashimoto H, Sumida T, Tsuchiya N.:
Association of PHRF1-IRF7 region polymorphism with clinical manifestations of systemic lupus erythematosus in a Japanese population.
Lupus 21(8):890-5.2012

97.Hashizume M, Yoshida H, Tanaka K, Suzuki M, Matsumoto I, Sumida T, Mihira M.:
Interleukine-6 regulates anti-arthritic effect of methotrexate via the reduction of SLC19A1 expression in mouse arthritis model.
Arthritis Res. Ther.14(2):R96,2012

98.Yamaguchi T, Ito S, Takano Y, Umeda N, Goto M, Horikoshi M, Hayashi T, Goto D, Matsumoto I, Sumida T.:
A case of a disseminated sporotrichosis patient treated with prednisolone, immunosuppressants, and tocilizumab under the diagnosis of rheumatoid arthritis.
Intern. Med.51(15):2035-9,2012

99.Tsuboi H, Matsuo N, Iizuka M, Tsuzuki S, Kondo Y, Tanaka A, Moriyama M, Matsumoto I, Nakamura S, Sumida T.:
Analysis of IgG4 class switch-related molecules in IgG4-related disease.
Arthritis Res. Ther. 14(4):R171,2012

100. Thomas G, Grunewald P, Bach H, Cossarizza A, Matsumoto I.:
The STEAP Protein Family: Versatile Oxidoreductases and Targets for Cancer Immunotherapy with Overlapping and Distinct Cellular Functions.
Biology of the Cell 104(11):641-57,2012

101.Inoue A, Matsumoto I, Tanaka Y, Umeda N, Tanaka Y, Mihara M, Takahashi S, Sumida T. :
TIARP (TNFAIP9) deficiency leads to arthritis via IL-6 overproduction with enhanced NF-kB, STAT3 signaling and dysregulated apoptosis of macrophages.
Arthritis Rheum 64(12):3877-85,2012

102.Suzuki T, Horikoshi M, Sugihara M, Hirota T, Ogishima H, Umeda N, Kondo Y, Tsuboi H, Hayashi T, Chino Y, Matsumoto I, Sumida T.:
Therapeutic efficacy of tocilizumab in patients with rheumatoid arthritis refractory to anti-tumor necrosis factor inhibitors: One year follow-up by low-field extremity MRI.
Mod. Rheumatol 23(4):782-7,2013

103.Sumida T, Iizuka M, Asashima H, Tsuboi H, Matsumoto I.：
Pathogenic role of anti-M3muscarinic acetylcholine receptor immune response in Sjogren's syndrome.
Presse Med.41(9 Pt 2):e461-6,2012

104.Iizuka M, Tsuboi H, Matsuo N, Kondo Y, Asashima H, Matsui M, Matsumoto I, Sumida T.:
The crucial roles of IFN-g in the development of M3 muscarinic acetylcholine receptor induced Sjogren's syndrome-like sialadenitis.
Mod. Rheumatol 23(3):614-6, 2013

105.Sumida T, Tsuboi H, Iizuka M, Asashima H, Matsumoto I.:
Anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjogren's syndrome.
Mod. Rheumatol 23(5): 841-5, 2013

106.Horikoshi M, Goto D, Segawa S, Yoshiga Y, Iwanami K, Inoue A, Tanaka Y, Matsumoto I, Sumida T.:
Activation of invariant NKT cells with glycolipid ligand α-galactosylceramide ameliorates glucose-6-phosphate isomerase peptide-induced arthritis.
PLoS One 7(12):e51215,2012

107.Umeda N, Matsumoto I, Ito I, Kawasaki A, Tanaka Y, Inoue A, Tanaka Y, Tsuboi H, Suzuki T, Hayashi T, Ito S, Tsuchiya N, Sumida T.:
Anti-citrullinated glucose-6-phosphate isomerase peptide antibodies in patients with rheumatoid arthritis are associated with HLA-DRB1 shared epitope alleles and disease activity.
Clin. Exp. Immunol 172(1):44-53,2013

108.Tsuboi H, Hagiwara S, Asashima H, Umehara H, Kawakami A, Nakamura H, Sano H, Tsubota K, Ogawa Y, Takamura E, Saito I, Inoue H, Nakamura S, Moriyama M, Takeuchi T, Tanaka Y, Hirata S, Mimori T, Matsumoto I, Sumida T.:
Validation of different sets of criteria for the diagnosis of Sjogren's syndrome in Japanese patients.
Mod. Rheumatol 23(2):219-25, 2013

109.Ito S, Ogishima H, Kondo Y, Sugihara M, Hayashi T, Chino Y, Goto D, Matsumoto I, Sumida T.:
Early diagnosis and treatment of steroid-induced diabetes mellitus in patients with rheumatoid arthritis and other connective tissue diseases.
Mod Rheumatol 21(1):52-59,2014

110.Furukawa H, Kawasaki A, Oka S, Shimada K, Masui T, Ikenaka T, Hashimoto A, Okazaki Y, Takaoka H, Futami H, Komiya A, Kondo Y, Ito S, Hayashi T, Matsumoto I, Kusaoi M, Takasaki Y, Nagai T, Hirohata S, Setoguchi K, Suda A, Nagaoka S, Kono H, Okamoto A, Chiba N, Suematsu E, Fukui N, Hashomoto H, Sumida T, Ono M, Tsuchiya N, Tohma S:
Association of a Single Nucleotide Polymorphism in the SH2D1A Intronic Region with Systemic Lupus Erythematosus.
Lupus 22(5):497-503,2013

111.Ogishima H, Tsuboi H, Umeda N, Horikoshi M, Kondo Y, Sugihara M, Suzuki T, Matsumoto I, Sumida T:
Analysis of subclinical synovitis detected by ultrasonography and low-field magnetic resonance imaging in patients with rheumatoid arthritis.
Mod Rheumatol 24(1)60-68,2014

112.Hagiya C, Tsuboi H, Yokosawa M, Hagiwara S, Takai C, Hirota T, Asashima H, Miki H, Umeda N, Horikoshi M, Kondo Y, Sugihara M, Ogishima H, Suzuki T, Hiraoka T, Kaji Y, Matsumoto I, Ohshika T, Sumida T.:
Clinicopathological features of IgG4-related disease complicated with orbital involvement.
Mod Rheumatol 24(3):471-6,2014

113.Tsuboi H, Asashima H, Takai C, Hagiwara S, Hagiya C, Yokosawa M, Hirota T, Umehara H, Kawakami A, Nakamura H, Sano H, Tsubota K, Ogawa Y, Takamura E, Saito I, Inoue H, Nakamura S, Moriyama M, Takeuchi T, Tanaka Y, Hirata S, Mimori T, Yoshifuji H, Ohta A, Matsumoto I, Sumida T.:
Primary and secondary surveys on epidemiology of Sjogren's syndrome in Japan.
Mod Rheumatol 24(3):464-70,2014

114.Sumida T, Tsuboi H, Iizuka M, Hirota T, H Asashima, Matsumoto I. :
The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjogren's syndrome: A Critical Review
J Autoimmunity 51:44-50,2014

115.Furukawa H, Kawasaki A, Oka S, Ito I, Shimada K, Sugii S, Hashimoto A, Komiya A, Fukui N, Kondo Y, Ito S, Hayashi T, Matsumoto I, Kusaoi M, Amano H, Nagai T, Hirohara S, Setoguchi K, Kono Hm Okamoto A, Chiba N, Suematsu E, Katayama M, Migita K, Suda A, Ohno S, Hashimoto H, Takasaki Y, Sumida T, Nagaoka S, Tsuchiya N, Tohma S.:
Human Leukocyte Antigens and Systemic Lupus Erythematosus: A Protective Role for the HLA-DR6 alleles DRB1*13:02 and *14:03.
PLoS One 9(2):e87792,2014

116.Iizuka M, Tsuboi H, Asashima H, Hirota T, Kondo Y, Matsui M, Matsumoto I, Sumida T.:
M3 muscarinic acetylcholine receptor reactive IL-17- producing T cells promotes development of Sjogren's syndrome like sialadenitis.
Mod Rheumatol 25(1):158-60, 2015

117.Sumida T, Tsuboi H, Asashima H, Iizuka M, Matsumoto I.:
Highlights from the 12th International Symposium on Sjogren's Syndrome in Kyoto, Japan.
Sjogren's Quarterly 9(1):8-14,2014

118.Hagiwara S, Tsuboi H, Hagiya C, Yokosawa M, Hirota T, Ebe H, Takahashi H, Ogishima H, Asashima H, Kondo Y, Umeda N, Suzuki T, Hitomi S, Matsumoto I, Sumida T.:
Pulmonary nocardiosis in patients with connective tissue disease: A report of two cases.
Intractable Rare Dis Res 3(1):25-28,2014

119.Segawa S, Goto D, Horikoshi M, Kondo Y, Umeda N, Hagiwara S, Yokosawa M, Hirota T, Miki H, Tsuboi H, Ogishima H, Suzuki T, Matsumoto I, Sumida T.：
Involvement of CD161+Vδ1+γδT cells in systemic sclerosis: Association with interstitial pneumonia.
Rheumatology(Oxford) 53(12):2259-69,2014

120.Matsumoto I, Inoue A, Takai C, Umeda N, Tanaka Y, Kurashima Y, Sumida T.:
Regulatory roles of tumor necrosis factor alpha-induced proteins (TNFAIP) 3 and 9 in arthritis.(Review)
Clin Immunol 153(1):73-8,2014

121.Ebe H, Tsuboi H, Hagiya C, Takahashi H, Yokosawa M, Hagiwara S, Hirota T, Kurashima Y, Takai C, Miki H, Asashima H, Umeda N, Kondo Y, Ogishima H, Suzuki T, Chino Y, Matsumoto I, Sumida T.:
Clinical features of patients with IgG4-related disease complicated with perivascular lesions.
Mod Rheumatol 25(1):105-9,2015

122.Tanaka Y, Matsumoto I, Inoue A, Umeda N, Takai C, Sumida T.:
Antigen-specific overexpression of human cartilage glycoprotein 39 on CD4+CD25+Foxp3+ Treg cells in the generation of glucose-6-phosphate isomerase induced arthritis.
Clin Exp Immunol 177(2):419-27,2014

123.Tsuboi H, Ohira H, Asashima H, Tsuzuki S, Iizuka M, Matsuo N, Kondo Y, Matsumoto I, Sumida T.:
Anti-M3 muscarinic acetylcholine receptor antibodies in patients with primary biliary cirrhosis.
Hepatol Res 44(14):E471-9,2014

124.Iizuka M, Wakasa Y, Tsuboi H, Asashima H, Hirota T, Kondo Y, Matsumoto I, Sumida T, Takaiwa F.:
Prophylactic effect of the oral administration of transgenic rice seeds containing altered peptide ligands of type II collagen on rheumatoid arthritis.
Biosci Biotech Bioch 78(10):1662-8,2014

125.Hirota T, Suzuki T, Hagiwara S, Ogishima H, Matsumoto I, Sumida T.:
Analysis of the usefulness of magnetic resonance imaging evaluation for rheumatoid arthritis treated with biological agents in the early phase: Retrospective observation of abatacept and infliximab.
Clin Exp Rheumatol 32(6):991,2014

126.Tsuboi H, Nakai Y, Iizuka M, Asashima H, Hagiya C, Tsuzuki S, Hirota T, Miki H, Hagiwara S, Kondo Y, Tanaka A, Moriyama M, Matsumoto I, Nakamura S, Yoshihara T, Abe K, Sumida T.:
DNA microarray analysis of labial salivary glands in IgG4-related disease. Comparison with Sjogren's syndrome.
Arthritis Rheum 66(10):2892-9,2014

127.Iizuka M, Wakasa Y, Tsuboi H, Asashima H, Hirota T, Kondo Y, Matsumoto I, Takaiwa F, Sumida T.:
Suppression of collagen-induced arthritis by oral administration of transgenic rice seeds expressing altered peptide ligands of type II collagen.
Plant Biotechnol J 12:(8):1143-53,2014

128.Tanaka K, Shiota j, Mikami M, Inoue Y, Sumida T, Matsumoto I, Muramoto K.:
The combined effects of iguratimod with anti-TNFα antibody on experimental arthritis models in mice.
Inflamm Regen 34(3):157-164,2014

129.Suzuki T, Hirota T, Ogishima H, Umeda N, Kondo Y, Yokosawa M, Miki H, Hagiwara S, Tsuboi H, Matsumoto I, Sumida T.:
Subclinical inflammation with tocilizumab treatment of rheumatoid arthritis: MRI evaluation for two years.
Int J Rheum Dis 18(1):108-10,2015

130.Tsuboi H, Matsumoto I, Hagiwara S, Hirota T, Takahashi H, Ebe H, Yokosawa M, Hagiya C, Asashima H, Takai C, Miki H, Umeda N, Kondo Y, Ogishima H, Suzuki T, Hirata S, Saito K, Tanaka Y, Horai Y, Nakamura H, Kawakami A, Sumida T.:
Efficacy and safety of abatacept for patients with Sjogren's syndrome associated with rheumatoid arthritis. ROSE (Rheumatoid Arthritis with Orencia Trial toward Sjogren's syndrome Endocrinopathy) trial. An open label, one-year, prospective study. Interim analysis of 32 patients for 24 weeks.
Mod Rheumatol 25(2):187-93,2015

131.Yokosawa M, Tsuboi H, Nasu K, Hagiya C, Hagiwara S, Hirota T, Ebe H, Takahashi H, Asashima H, Kondo Y, Ogishima H, Suzuki T, Minami M, Bukawa H, Matsumoto I, Sumida T.:
Usefulness of MR imaging of the parotid glands in patients with secondary Sjogren’s syndrome associated with rheumatoid arthritis.
Mod Rheumatol 25(3):415-20,2015

132.Tahara M, Kondo Y, Yokosawa M, Tsuboi H, Satoru T, Sibayama S, Matsumoto I, Sumida T. :
T-bet regulates differentiation of forkhead box protein 3+ regulatory T cells in programmed cell death-1-deficient mice..
Clin Exp Immunol 179(2):197-209,2015

133.Kawasaki A, Furukawa H, Nishida N, Warabi E, Kondo Y, Ito S, Matsumoto I, Kusaoi M, Amano H, Suda A, Nagaoka S, Setoguchi K, Nagai T, Hirohata S, Shimada K, Sugai S, Okamoto A, Chiba N, Suematsu E, Ohno S, Katayama M, Okamoto A, Kono H, Tokunaga K, Takasaki Y, Hashimoto H, Sumida T, Tohma S, Tsuchiya N.:
Association of Functional Polymorphisms in Interferon Regulatory Factor 2 (IRF2) with Susceptibility to Systemic Lupus Erythematosus: a Case-Control Association Study.
PLoS One 9(10):e109764,2014

134.Takahashi H, Tsuboi H, Kurata I, Takahashi H, Inoue S, Ebe H, Yokosawa M, Hagiwara S, Hirota T, Asashima H, Kaneko S, Kawaguchi H, Kurashima Y, Miki H, Umeda N, Kondo Y, Ogishima H, Suzuki T, Matsumoto I, Sumida T.:
Predictors of the response to treatment in acute lupus 1 hemophagocytic syndrome.
Lupus 24(7):659-68,2015

135.Iizuka M, Tsuboi H, Matsuo N, Asashima H, Hirota T, Kondo Y, Iwakura Y, Takahashi S, Matsumoto I, Sumida T.:
A crucial role of RORgt in the development of spontaneous sialadenitis-like Sjogren's syndrome.
J Immunol 194(1):56-67,2015

136.Kurata I, Tsuboi H, Takahashi H, Inoue S, Ebe H, Hagiwara S, Umeda N, Kondo Y, Ogishima H, Suzuki T, Matsumoto I, Hoshi S, Oshika T, Sumida T.:
Successful treatment with infliximab for refractory uveitis in a patient with Behcet's disease on hemodialysis and a review of literature for infliximab use on hemodialysis.
Intern Med 54(12):1553-7,2015

137.Takahashi H, Tsuboi H, Ogishima H, Yokosawa M, Takahashi H, Yagishita M, Abe S, Hagiwara S, Asashima H, Umeda N, Kondo Y, Suzuki T, Matsumoto I, Sumida T.:
FDG-PET/CT can reveal subclinical prostatitis in a patient with IgG4-related disease.
Rheumatology (Oxford) 54(6):1113,2015

138.Kurata I, Tsuboi H, Takahashi H, Yagishita M, Abe S, Ebe H, Takahashi H, Asashima H, Hirota T, Hagiwara S, Umeda N, Kondo Y, Ogishima H, Suzuki T, Matsumoto I, Sumida T.:
A case of relapsing neurosarcoidosis with brain nodules and hydrocephalus successfully treated by corticosteroid and methotrexate.
Rheumatology (Oxford) 54(7):1160,2015

139.Takai C, Matsumoto I, Inoue A, Umeda N, Tanaka Y, Kurashima Y, Wada Y, Narita I, Sumida T.:
Specific overexpression of TNFAIP9 in CD14+CD16- monocytes in patients
with rheumatoid arthritis- Comparative analysis with TNFAIP3.
Clin Exp Immunol 180(3):458-66,2015

140.Kondo Y, Yao Z, Tahara M, Izuka M, Yokosawa M, Kaneko S, Tsuboi H, Yoh K, Takahashi S, Matsumo I, Sumida T.:
Involvement of RORγt-overexpressing T cells in the development of autoimmune arthritis in mice.
Arthritis Res Ther 17(1):105,2015

141.Asashima H, Tsuboi H, Iizuka M, Hirota T, Kondo Y, Matsumoto I, Sumida T.:
The Anergy Induction of M3 Muscarinic Acetylcholine Receptor-Reactive CD4+ T Cells Suppresses Experimental Sialadenitis-like Sjogren's Syndrome.
Arthritis Rheum 67(8):2213-25,2015

142.Yoon JH, Sudo K, Kuroda M, Kato M, Lee I, Nakae S, Imamura T, Kim J,Ju JH, Matsuzaki K, Matsumoto I, Sumida T, Mamura M.:
Phosphorylation status determines the divergent roles of TGF-β recepter-regulated Smad in STAT3-induced TH17 differentiation.
Nat Commun 21;6:7600,2015

143.Hirota T, Suzuki T, Ogishima H, Hagiwara S, Ebe H, Takahashi H, Yokosawa M, Umeda N, Kondo Y, Tsuboi H, Matsumoto I, Sumida T.:
Evaluation of changes in magnetic resonance images following 24 and 52 weeks treatment of rheumatoid arthritis with infliximab, tocilizumab or abatacept.
Mod Rheumatol 26(1):29-35,2016

144.Takahashi H, Tsuboi H, Abe S, Yokosawa M, Hagiwara S, Asashima H, Hirota T, Umeda N, Kondo Y, Matsumoto I, Sumida T.:
Magnetic resonance imaging can reveal fascial vasculitis in a patient with microscopic polyangiitis.
Scand J Rheumatol 44(6):511-3,2015

145.Seri Y, Shoda H, Suzuki A, Matsumoto I, Sumida T, Fujio K, Yamamoto K.:
Peptidylarginine deiminase type 4 deficiency reduced arthritis severity in a glucose-6-phosphate isomerase-induced arthritis model.
Sci Rep 21;5:13041,2014

146.Umeda N, Matsumoto I, Kawaguchi H, Kurashima Y, Kondo Y, Tsuboi H, Ogishima H, Suzuki T, Kagami Y, Sakyu T, Ishigami A, Maruyama N, Sumida T.:
Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases.
Clin Rheumatol 35(5):1181-8,2016

147.Miki H, Tsuboi H, Kaneko S, Takahashi H, Yokosawa M, Asashima H, Hirota T, Hagiwara S, Umeda N, Kondo Y, Nishimura B, Sugano M, Matsumoto I, Sumida T.:
A case of refractory Kimura disease with a buccal bulky mass successfully treated with
low-dose cyclosporine A: report and review of the literature.
Allergol Int 65(2):212-4,2016

148.Hagiwara S, Tsuboi H, Honda F, Takahashi H, Kurata I, Ohyama A, Yagishita M, Abe S, Kurashima Y, Kaneko S, Kawaguchi H, Takahashi H, Ebe H, Yokosawa M, Asashima H, Hirota T, Umeda N, Kondo Y, Matsumoto I, Sumida T.:
Association of anti-Ro/SSA antibody with response to biologics in patients with
rheumatoid arthritis.
Mod Rheumatol 26(6):857-862,2016

149.Tsuboi H, Matsumoto I, Hagiwara S, Hirota T, Takahashi H, Ebe H, Yokosawa M, Yagishita M, Takahashi H, Kurata I, Ohyama A, Honda F, Asashima H, Miki H, Umeda N, Kondo Y, Hirata S, Saito K, Tanaka Y, Horai Y, Nakamura H, Kawakami A, Sumida T.:
Effectiveness of abatacept for patients with Sjoren's syndrome associated with rheumatoid arthritis. An open label, multicenter, one-year, prospective study: ROSE (Rheumatoid Arthritis with Orencia Trial toward Sjoren's syndrome Endocrinopathy) trial.
Mod Rheumatol 26(6):891-899,2016

150.Segawa S, Goto D, Iizuka A, Kaneko S, Yokosawa M, Kondo Y, Matsumoto I, Sumida T.:
The regulatory role of IFN-g producing gammadelta T cells via the suppression of Th17 cell activity in bleomycin-induced pulmonary fibrosis.
Clin Exp Immunol 185(3):348-60,2016

151.Hachiya Y, Kawasaki A, Oka S, Kondo Y, Ito S, Matsumoto I, Kusaoi M, Amano H, Suda A, Setoguchi K, Nagai T, Shimada K, Sugii S, Okamoto A, Chiba N, Suematsu E, Ohno S, Katayama M, Kono H, Hirohata S, Takasaki Y, Hashimoto H, Sumida T, Nagaoka S, Tohma S, Furukawa H, Tsuchiya N.:
Association of HLA-G 3' Untranslated Region Polymorphisms with Systemic Lupus Erythematosus in a Japanese Population: a Case-control Association Study.
PLoS One 11(6):e0158065,2016

152.Hirota T, Tsuboi H, Iizuka-Koga M, Takahashi H, Asashima H, Yokosawa M, Kondo Y, Ohta M, Wakasa Y, Matsumoto I, Takaiwa F, Sumida T.:
Suppression of glucose-6-phosphate-isomerase induced arthritis by oral administration of transgenic rice seeds expressing altered peptide ligands of
glucose-6-phosphate-isomerase.
Mod Rheumatol 27(3):457-465,2017

153.Tahara M, Tsuboi H, Segawa S, Asashima H, Iizuka M, Hirota T, Takahashi H, Kondo Y, Matsui M, Matsumoto I, Sumida T.:
RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjogren's syndrome-like sialadenitis.
Clin Exp Immunol 187(2):213-224,2017

154.Inoue A, Matsumoto I, Tanaka Y, Umeda N, Takai C, Kawaguchi H, Ebe H, Yoshida H, Matsumoto Y, Segawa S, Takahashi S, Sumida T.:
TIARP attenuates autoantibody-mediated arthritis via the suppression of neutrophil migration by reducing CXCL2/CXCR2 and IL-6 expression.
Sci Rep 6:38684,2016

155.Yokosawa M, Kondo Y, Tahara M, Iizuka M, Segawa S, Kaneko S, Tsuboi H, Yoh K, Takahashi S, Matsumoto I, Sumida T.:
T-bet overexpression regulates AHR-mediated Th-17 differentiation through an IFNγ-independent pathway.
Clin Exp Immunol 188(1):22-35,2017

156.Umeda N, Matsumoto I, Tanaka Y, Kawaguchi H, Ebe H, Kagami Y, Ishigami A, Sumida T.:
Anti-cyclic citrullinated glucose-6-phosphate isomerase peptide -7 (CCG-7) antibodies were suppressed by biologics treatment and deposited to citrullinated proteins in CD68-positive cells in the RA synovium.
Mod Rheumatol 35(5):1181-8,2016

157.Abe S, Tsuboi H, Toko H, Honda F, Ohyama A, Takahashi H, Yokosawa M, Asashima H, Hagiwara S, Hirota T, Kondo Y, Matsumoto I, Sakai S, Aonuma K, Sumida T.:
The effectiveness of upfront pulmonary vasodilators combination therapy in addition to corticosteroids for pulmonary arterial hypertension associated with systemic lupus erythematosus: two successful cases utilizing both corticosteroids and an upfront combination of vasodilators.
Modern Rheumatol Case Reports 1(2):73-78,2017

158.Tsuboi H, Hagiwara S, Asashima H, Takahashi H, Hirota T, Umehara H, Kawakami A, Nakamura H, Sano H, Tsubota K, Ogawa Y, Takamura E, Saito I, Inoue H, Nakamura S, Moriyama M, Takeuchi T, Tanaka Y, Hirata S, Mimori T, Matsumoto I, Sumida T.:
Comparison of the performance of new ACR-EULAR classification criteria for primary Sjogren's syndrome with former sets of criteria in Japanese patients.
Ann Rheum Dis 76(12):1980-1985,2017

159.Iizuka-Koga M, Asashima H, Ando M, Lai C-Y, Mochizuki S, Nakanishi M, Nishimura T, Tsuboi H, Hirota T, Takahashi H, Masumoto I, Otsu M, Sumida T.:
Functional analysis of dendritic cells generated from T-iPS cells from CD4+ T cell clones of Sjogren's syndrome.
Stem Cell Reports 8(5):1155-1163,2017

160.Honda F, Tsuboi H, Toko H, Ohyama A, Takahashi H, Abe S, Yokosawa M, Asashima H, Hagiwara S, Hirota T, Kondo Y, Matsumoto I, Sumida T.:
Recurrent Kikuchi-Fujimoto disease successfully treated by concomitant use of hydroxychloroquine and corticosteroid.
Intern Med 56(24):3373-3377,2017

161.Takahashi H, Tsuboi H, Asashima H, Hirota T, Kondo Y, Moriyama M, Matsumoto I, Nakamura S, Sumida T.:
cDNA microarray analysis identifies NR4A2 as a novel molecule involved in the pathogenesis of Sjogren's syndrome.
Clin Exp Immunol 190(1):96-109,2017

162.Takahashi H, Tsuboi H, Yokosawa M, Asashima H, Hirota T, Kondo Y, Matsumoto I, Sumida T.:
Diffusion-weighted magnetic resonance imaging of parotid glands before and after abatacept therapy in patients with Sjogren's syndrome associated with rheumatoid arthritis: Utility to evaluate and predict response to treatment.
Mod Rheumatol 28(2):300-307,2018

163.Kawaguchi H, Tsuboi H, Yagishita M, Terasaki T, Terasaki M, Shimizu M, Honda F, Ohyama A, Takahashi H, Miki H, Yokosawa M, Asashima H, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.:
A case of severe adult-onset Still disease with constrictive pericarditis and pleuritis successfully treated with tocilizumab in addition to corticosteroid and cyclosporin A.
Intern Med 57(7):1033-1038,2018

164.Ebe H, Matsumoto I, Kawaguchi H, Kurata I, Tanaka Y, Inoue A, Kondo Y, Tsuboi H, Sumida T.
Clinical and functional significance of STEAP4-splice variant in CD14⁺ monocytes in patients with rheumatoid arthritis.
Clin Exp Immunol 191(3):338-348,2018

165.Kondo Y, Yokosawa M, Kaneko S, Furuyama K, Segawa S, Tsuboi H, Matsumoto I, Sumida T.
Transcriptional regulation of CD4+ T cell differentiation in experimentally-induced arthritis and rheumatoid arthritis.
Arthritis Rheum 70(5):653-661,2018

166.Yagishita M, Kondo Y, Terasaki T, Terasaki M, Shimizu M, Honda F, Oyama A, Takahashi H, Yokosawa M, Asashima H, Hagiwara S, Tsuboi H, Matsumoto I, Sumida T.
A case of clinically amyopathic dermatomyositis with interstitial pneumonia successfully treated with plasma exchange.
Intern Med 57(13):1935-1938,2018

167.Kaneko S, Kondo Y, Yokosawa M, Furuyama K, Segawa S, Tsuboi H, Kanamori A, Matsumoto I, Yamazaki M, Sumida T.:
The RORgt-CCR6-CCL20 axis augments Th17 cells invasion into the synovia of rheumatoid arthritis patients.
Mod Rheumatol 28(5):814-825,2018

168.Honda F, Tsuboi H, Toko H, Terasaki T, Terasaki M, Shimizu M, Ohyama A, Yagishita M, H, Takahashi H, Yokosawa M, Asashima H, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.
Contrast enhanced computed tomography revealed gallbladder hemorrhage due to active vasculitis in a patient with microscopic polyangiitis.
J Clin Rheumatol 25(6):e84-e85,2019

169.Takahashi H, Tsuboi H, Umeda N, Toko H, Honda F, Ohyama A, Abe S, Yokosawa M, Asashima H, Hagiwara S, Kondo Y, Matsumoto I, Hirose Y, Hara A, Sumida T.:
A case of otitis media with ANCA-associated vasculitis accompanied with pituitary mass successfully treated by corticosteroids.
Modern Rheumatol Case Reports 2(2)185-190,2018

170.Toko H, Tsuboi H, Umeda N, Honda F, Ohyama A, Takahashi H, Abe S, Yokosawa M, Asashima H, Hagiwara S, Hirota T, Kondo Y, Matsumoto I, Sumida T.:
A case of intractable hemophagocytic syndrome associated with systemic lupus erythematosus resistant to corticosteroids and intravenous cyclophosphamide that was successfully treated by cyclosporine A.
Intern Med 57(18):2747-2752,2018

171.Kawaguchi H, Matsumoto I, Osasda A, Kurata I, Ebe H, Tanaka Y, Inoue A, Umeda N, Kondo Y, Tsuboi H, Shinkai Y, Kumagai Y, Ishigami A, Sumida T.:
Identification of novel biomarker as citrullinated inter-alpha-trypsin inhibitor heavy chain 4, specifically increased in sera with experimental and rheumatoid arthritis.
Arthritis Res Ther 20(1):66,2018

172.Ohyama A, Tsuboi H, Noma H, Terasaki M, Shimizu M, Toko H, Honda F, Yagishita M, Takahashi H, Asasahima H, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.:
Associations between maternal clinical features and fetal outcomes in pregnancies of mothers with connective tissue diseases.
Mod Rheumatol 29(2):344-350,2019

173.Shimizu M, Asashima H, Terasaki M, Toko H, Honda F, Ohyama A, Yagishita M, Takahashi H, Hagiwara S, Kondo Y, Tsuboi H, Matsumoto I, Sumida T.:
Renal sarcoidosis with multiple organ involvements.
J Clin Rheumatol 26(3):e55,2020

174.Ebe H, Matsumoto I, Osada A, Kurata I, Kawaguchi H, Kondo Y, Tsuboi H, Sumida T.:
Splice variant of STEAP4 localizes in the nucleus, making it a possible transcriptional regulator of IL-6 production.
Mod Rheumatol 29(4):714-716,2019

175.Iizuka A, Segawa S, Kondo Y, Kaneko S, Yokosawa M, Furuyama K, Miki H, Tahara-Hanaoka S, Shibuya A, Tsuboi H, Goto D, Matsumoto I, Shibayama S, Sumida T.:
Allergy inhibitory receptor-1 inhibits autoantibody production via upregulation of apoptotic debris clearance by macrophages.
Int J Rheum Dis 21(12):2071-2078,2018

176.Segawa S, Kondo Y, Nakai Y, Iizuka A, Kaneko S, Yokosawa M, Furuyama K, Tsuboi H, Goto D, Matsumoto I, Sumida T.:
Placenta specific-8 suppresses IL-18 production through regulation of autophagy and is associated with Adult Still’s disease.
J Immunol 201(12):3535-3545,2018

177.Kawaguchi H, Matsumoto I, Osada A, Kurata I, Ebe H, Tanaka Y, Inoue A, Umeda N, Kondo Y, Tsuboi H, Ishigami A, Sumida T.:
Peptidyl arginine deiminase inhibition suppresses arthritis via decreased protein citrullination in joints and serum with the downregulation of interlukin-6.
Mod Rheumatol 29(6):964-969,2019

178.Kurata I, Tsubio H, Terasaki M, Shimizu M, Toko H, Honda F, Ohyama A, Yagishita M, Osada A, Kaneko S, Ebe H, Kawaguchi H, Takahashi H, Hagiwara S, Asashima H, Kondo Y, Matsumoto I, Sumida T.:
Effect of biological disease modifying anti-rheumatic drugs on airway and interstitial lung disease in patients with rheumatoid arthritis.
Intern Med 58(12):1703-1712,2019

179.Tsuboi H, Iizuka-Koga M, Asashima H, Takahashi H, Kudo H, Ono Y, Honda F, Iizuka A, Segawa S, Abe S, Yagishita M, Yokosawa M, Kondo Y, Moriyama M, Matsumoto I, Nakaramura S, Sumida T.
Up-regulation and pathogenic roles of CCL18-CCR8 axis in IgG4-related disease.
Mod Rheumatol 30(4):729-737,2020

180.Kurata I, Matsumoto I, Ohyama A, Osada A, Ebe H, Kawaguchi H, Kaneko S, Kondo Y, Tsuboi H, Tomioka A, Kaji H, Sumida T.:
Potential involvement of OX40 in the regulation of autoantibody sialylation in arthritis.
Ann Rheum Dis 78(11):1488-1496,2019

181.Hagiwara S, Tsuboi H, Terasaki T, Terasaki M, Toko H, Shimizu M, Honda F, Yagishita M, Ohyama A, Takahashi H, Yokosawa M, Asashima H, Kondo Y, Matsumoto I, Sumida T.:
Association of anti-cyclic citrullinated peptide antibody with clinical features in patients with psoriatic arthritis.
Mod Rheumatol 30(2):365-372,2020

182.Tsuboi H, Honda F, Takahashi H, Ono Y, Abe S, Kondo Y, Matsumoto I, Sumida T.:
Pathogenesis of IgG4-related disease. Comparison with Sjogren's syndrome.
Mod Rheumatol 30(1):7-16,2020

183.Matsumoto I, Kurata I, Ohyama A, Kawaguchi H, Ebe H, Osada A, Kondo Y, Tsuboi H, Sumida T.:
Revisit of autoimmunity to glucose-6-phosphate isomerase in experimental and rheumatoid arthritis.
Mod Rheumatol 30(2):232-238,2020

184.Kudo H, Tsuboi H, Asashima H, Takahashi H, Ono Y, Abe S, Honda F, Kondo Y, Wakasa Y, Takaiwa F, Takano M, Matsui M, Matsumoto I, Sumida T.:
Transgenic rice seeds expressing altered peptide ligands against the M3 muscarinic acetylcholine receptor suppress experimental sialadenitis-like Sjogren's syndrome.
Mod Rheumatol 30(5):884-893,2020

185.Sato R, Takahashi H, Terasaki M, Okamoto S, Terasaki T, Toko H, Yagishita M, Hagiwara S, Kondo Y, Tsuboi H, Matsumoto I, Sumida T.:
Advantage of magnetic resonance imaging in detecting tracheal involvement and evaluation of the therapeutic effect in relapsing polychondritis with asthma-like symptoms.
J Clin Rheumatol (in press)

186.Terasaki M, Takahashi H, Sato R, Okamoto S, Terasaki T, Toko H, Yagishita M, Hagiwara S, Kondo Y, Tsuboi H, Matsumoto I, Sumida T.:
Successful treatment with multitarget therapy of mycophenolate mofetil and tacrolimus for cyclophosphamide-resistant ANCA-associated pauci-immune glomerulonephritis developed independently of systemic lupus erythematosus.
J Clin Rheumatol (in press)

187.Nishiyama T, Kondo Y, Okamoto S, Terasaki M, Toko H, Yagishita M, Takahashi H, Yokosawa M, Tsuboi H, Matsumoto I, Sumida T.:
Aortic arch aneurysm in Behcet disease successfully treated with infliximab.
Intern Med 59(8):1087-1091,2020

188.Ono Y, Tsuboi H, Moriyama M, Asashima H, Kudo H, Takahashi H, Honda F, Abe S, Kondo Y, Takahashi S, Nakamura S, Matsumoto I, Sumida T.:
RORγt antagonist improves Sjogren's syndrome-like sialadenitis through downregulation of CD25.
Oral Dis 26(4):766-777,2020

189.Okamoto S, Tsuboi H, Sato R, Terasaki T, Toko H, Shimizu M, Honda F, Yagishita M, Ohyama A, Kurata I, Abe S, Takahashi H, Osada A, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.:
IgG4-related pleural disease with aortitis and submandibular glands involvement successfully treated with corticosteroid: case-based review.
Rheumatol Int 40(10):1725-1732,2020

190.Kurata I, Matsumoto I, Sumida T.:
T follicular helper cell subsets: a potential key player in autoimmunity.
Immunol Med(in press)

191.Abe S, Tsuboi H, Kudo H, Asashima H, Ono Y, Honda F, Takahashi H, Yagishita M, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.:
Identification of M3 muscarinic acetylcholine receptor reactive Th17 cells in patients with primary Sjogren's syndrome.
JCI insight 5(15):e135982,2020

192.Terasaki T, Kondo Y, Takahashi M, Tawara T, Fujita A, Yagi H, Kawai H, Noguchi M, Sato R, Terasaki M, Okamoto S, Toko H, Yagishita M,
Takahashi H, Hagiwara S, Tsuboi H, Matsumoto I, Sumida T.:
Therapeutic plasma exchange improved pregnancy-associated thrombotic microangiopathy but not pregnancy outcome in patient with systemic lupus erythematosus.
Intern Med 59(24):3235-3238,2020

193.Tsuboi T, Suzuki H, Akutsu D, Terasaki T, Okamoto S, Kondo Y, Matsumoto I, Mizokami Y, Sumida T.:
The pathologically confirmed esophageal involvement of idiopathic multicentric Castleman’s disease mimicking early esophageal cancer.
Rheumatology(Oxford) (in press)

194.Yagishita M, Tsuboi H, Tabuchi D, Sugita T, Nishiyama T, Okamoto S, Terasaki T, Shimizu M, Honda F, Ohyama A, Kurata I, Abe S, Takahashi H, Osada A, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.:
Clinical features and prognosis of nocardiosis in patients with connective tissue diseases.
Mod Rheumatol (in press)

195.Osada A, Matsumoto I, Mikami N, Ohyama A, Kurata I, Kondo Y, Tsuboi H, Ishigami A, Sano Y, Arai T, Ise N, Sumida T.:
Citrullinated inter-alpha-trypsin inhibitor heavy chain 4 in arthritic joints and its potential effect in the neutrophil migration.
Clin Exp Immunol (in press)

196.Morinaka S, Tsuboi H, Hagiwara S, Sugita T, Tabuchi D, Sato R, Nishiyama T, Okamoto S, Terasaki T, Yagishita M, Takahashi H, Kondo Y, Matsumoto I, Sumida T.:
Clinical features of large vessel vasculitis (LVV): Elderly-onset versus young-onset.
Mod Rheumatol (in press)

197.Nishiyama T, Kondo Y, Tsuboi H, Noma H, Tabuchi D, Sugita T, Okamoto S, Terasaki T, Shimizu M, Honda F, Ohyama A, Kurata I, Yagishita M, Abe S, Takahashi H, Osada A, Hagiwara S, Matsumoto I, Sumida T.:
QTc interval prolongation in patients with systemic lupus erythematosus treated with hydroxychloroquine.
Mod Rheumatol (in press)

198.Takahashi H, Tsuboi H, Abe S, Honda F, Kondo Y, Matsumoto I, Sumida T.:
Humanized NOD/SCID/IL2rγnull mice exhibit functionally augmented human regulatory T cells associated with enzymatic upregulation of H3K27me3 in comparison with humans.
Clin Exp Immunol (in press)

199.Okamoto S, Kondo Y, Sato K, Nishiyama T, Toko H, Yagishita M, Yokosawa M, Tsuboi H, Ieda M, Matsumoto I.:
Anti-PL-7 antibody positive antisynthetase syndrome diagnosed after the onset of pulmonary hypertension and right-sided heart failure.
Rheumatology (in press)

200.Okamoto S, Tsuboi H, Noma H, Tabuchi D, Sugita T, Nishiyama T, Terasaki T, Shimizu M, Honda F, Yagishita M, Ohyama A, Kurata I, Abe S, Takahashi H, Osada A, Hagiwara S, Kondo Y, Matsumoto I, Sumida T.:
Predictive factors for pneumomediastinum during management of connective tissue diseaserelated interstitial lung disease: A retrospective study.
Intern Med (in press)

201.Shimoyama S, Nakagawa I, Jiang JJ, Matsumoto I, Chiorini JA, Hasegawa Y, Ohara O, Hasebe R, Ota M, Uchida M, Kamimura D, Hojyo S, Tanaka Y, Atsumi T, Murakami M.:
Sjogren's syndrome-associated SNPs increase GTF2I expression in salivary gland cells to enhance inflammation development.
Int Immunol (in press)

202.Ichimura Y, Konishi R, Shobo M, Inoue S, Okune M, Maeda A, Tanaka R, Kubota N, Matsumoto I, Ishii A, Tamaoka A, Shimbo A, Mori M, Morio T, Kishi T, Miyamae T, Tanboon J, Inoue M, Nishino I, Fujimoto M, Nomura T, Okiyama N.:
Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rash.
Rheumatology (Oxford) (in press)

203.Kurata I, Mikami N, Ohyama A, Osada A, Kondo Y, Tsuboi H, Sumida T, Matsumoto I.:
Impaired function of PD-1+ follicular regulatory T cells in systemic lupus erythematosus.
Clin Exp Immunol (in press)

204.Ohyama A, Osada A, Kawaguchi H, Kurata I, Nishiyama T, Iwai T, Kondo Y, Tsuboi H, Sumida T, Matsumoto I.:
Specific increase in joint neutrophil extracellular traps and its relation to interleukin 6 in autoimmune arthritis.
Int J Mol Sci (in press)

205.Honda F, Tsuboi H, Ono Y, Abe S, Takahashi H, Ito K, Yamada K, Kawano M, Kondo Y, Asano K, Tanaka M, Mallsen M, Mallsen B, Matsumoto I, Sumida T.:
Pathogenic roles and therapeutic potential of the CCL8-CCR8 axis in a murine model of IgG4-related sialadenitis.
Arthritis Res Ther (in press)

206.Shimizu M, Kondo Y, Tanimura R, Furuyama K, Yokosawa M, Asashima H, Tsuboi H, Matsumoto I, Sumida T.:
T-bet represses collagen-induced arthritis by suppressing Th17 lineage commitment through inhibition of RORgt expression and function.
Sci Rep (in press)

207.Furuyama K, Kondo Y, Shimizu M, Yokosawa M, Segawa S, Iizuka A, Tanimura R, Tsuboi H, Matsumoto I, Sumida T.:
RORγt⁺Foxp3⁺ regulatory T cells in the regulation of autoimmune arthritis.
Clin Exp Immunol (in press)